Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease.

Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease.

Item
http://www.wikidata.org/entity/Q46898222
Economic evaluation of cholesterol-related interventions in general practice. An appraisal of the evidence.The limited incorporation of economic analyses in clinical practice guidelines.Statins: balancing benefits, efficacy and safety.Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment.Cost effectiveness of statins in coronary heart disease.The challenges of treating peripheral arterial disease.Secondary prevention of hypercholesterolaemia: results of an audit conducted in South Wales.Effectiveness calculation in economic analysis: the case of statins for cardiovascular disease prevention.Cost of a pharmacist-directed intervention to increase treatment of hypercholesterolemia.Quality assessment of economic analyses of pharmacological and nutritional therapy for hyperlipidemia.Cost-effectiveness of HMG-CoA reductase inhibitors in the treatment of dyslipidemia and prevention of CHD.A pharmacoeconomic evaluation of statins in the treatment of hypercholesterolaemia in the primary care setting in Spain.Testing strategies for diagnosing lupus anticoagulant: Decision analysis
P2860

Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease.

Item
http://www.wikidata.org/entity/Q46898222
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease.
@en
Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease.
@nl
type
label
Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease.
@en
Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease.
@nl
prefLabel
Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease.
@en
Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease.
@en
P2093
P304
P31
P356
10.1016/S0002-9149(96)00328-1
P407
P433
P478
P577
P698